Six years after the FDA approved…
Six years after the FDA approved Eli Lilly’s Retevmo to [...]
Cyrano Therapeutics is savoring a…
Cyrano Therapeutics is savoring a phase 2 victory. With the [...]
Vaccine Makers Curtail Research and Cut Jobs
Federal policies under Robert F. Kennedy Jr. that are hostile [...]
Should Drug Companies Be Advertising to Consumers?
Aging means “becoming a target” of the industry, one expert [...]
The FDA has rejected a rare blood…
The FDA has rejected a rare blood disease candidate from [...]
Just as a disciplined soccer…
Just as a disciplined soccer player might pass on a [...]
After a string of high-profile…
After a string of high-profile regulatory rebukes, Biohaven’s CEO believes [...]
Determined to avoid a repeat of…
Determined to avoid a repeat of the supply shortfalls that [...]
Friday’s RFI sets a March 19…
Friday’s RFI sets a March 19 deadline for stakeholders to [...]
A new campaign for Astellas…
A new campaign for Astellas Pharma’s Izervay is aimed at [...]